Genitourinary Cancer
Conference Coverage
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
News
More Side Effects With Local Therapies for Prostate Cancer
What impact does local therapy have on the men’s quality of life?
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Baseline PSA testing in Black men should begin at age 40-45, and should be followed by regular screening intervals, preferably annually.
Conference Coverage
Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North America
The Stockholm3 blood test, using a multiplex algorithm, shows benefits over PSA in a diverse, multi-ethnic cohort beyond a Swedish population...
Conference Coverage
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
News
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
News
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All Matter
New study sheds light on quality of life effects related to disease severity and treatment choice.
News
Prostate Risks Similar for Testosterone Therapy and Placebo
Uncertainty and concern exist about a link between prostate cancer risk and testosterone levels.
News
Radiation Oncologists Fight for Payment Reform Amid Cuts
Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for...
News
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.